Clincosm LogoSign in Get a demo

primary immune thrombocytopenia

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • STSA-1301 subcutaneous injection
  • Placebo
  • Beijing, Chaoyang District, China
    Beijing Ditan Hospital,Capital Medical University
Nov 28, 2023

Pediatric Primary Immune Thrombocytopenia (ITP)

Recruiting
  • Primary Immune Thrombocytopenia
  • data collection
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023

Fostamatinib in Patients With ITP. FOSTASUR Study

Completed
  • Primary Immune Thrombocytopenia
  • Cadiz, Cádiz, Spain
  • +13 more
Oct 3, 2023

Primary Immune Thrombocytopenia Trial in Worldwide (efgartigimod PH20 SC)

Recruiting
  • Primary Immune Thrombocytopenia
  • efgartigimod PH20 SC
  • Bentonville, Arkansas
  • +70 more
Jan 31, 2023

Primary Immune Thrombocytopenia Trial in Worldwide (PF-06835375)

Suspended
  • Primary Immune Thrombocytopenia
  • PF-06835375
  • Jacksonville, Florida
  • +27 more
Jan 25, 2023

Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 23, 2023

Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab)

Completed
  • Primary Immune Thrombocytopenia
  • Boston, Massachusetts
  • +26 more
Jan 16, 2023

Primary Immune Thrombocytopenia Trial in China (Orelabrutinib( lower dose), Orelabrutinib( higher dose))

Recruiting
  • Primary Immune Thrombocytopenia
  • Orelabrutinib( lower dose)
  • Orelabrutinib( higher dose)
  • HaiKou, Hainan, China
  • +8 more
Jan 10, 2023

Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide

Recruiting
  • Healthy
  • +2 more
  • PF-06755347 intravenous healthy participant
  • +4 more
  • New Haven, Connecticut
  • +5 more
Dec 29, 2022

Primary Immune Thrombocytopenia Trial in Spain (Romiplostim plus dexamethasone, Dexamethasone)

Recruiting
  • Primary Immune Thrombocytopenia
  • Barcelona, Spain
  • +14 more
Dec 22, 2022

Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

Completed
  • Primary Immune Thrombocytopenia
  • Shandong, China
    Qilu Hospital of Shandong University
Nov 20, 2022

Primary Immune Thrombocytopenia Trial in Guadalajara (Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet)

Completed
  • Primary Immune Thrombocytopenia
  • Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Sep 20, 2022

Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab, Placebo)

Terminated
  • Primary Immune Thrombocytopenia
  • Beverly Hills, California
  • +48 more
Aug 17, 2022

Primary Immune Thrombocytopenia Trial in Worldwide (Efgartigimod PH20 SC, Placebo PH20 SC)

Recruiting
  • Primary Immune Thrombocytopenia
  • Efgartigimod PH20 SC
  • Placebo PH20 SC
  • Springdale, Arkansas
  • +185 more
Aug 17, 2022

Primary Immune Thrombocytopenia Trial in Ukraine (Intravenous immunoglobulin (IVIG), 10% solution for infusion)

Recruiting
  • Primary Immune Thrombocytopenia
  • Intravenous immunoglobulin (IVIG), 10% solution for infusion
  • Kropyvnytskyi, Ukraine
  • +5 more
Aug 9, 2022

Some Cytokines Expression in ITP Primary Immune Thrombocytopenic

Recruiting
  • Primary Immune Thrombocytopenia
  • Plasma RNA isolation, qPCR analysis of micro RNA
  • +2 more
  • Sohag, Egypt
    Sohag University
May 7, 2022

Evaluate Safety and Effectiveness of Hetrombopag in ITP or AA

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • Aplastic Anemia
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Apr 11, 2022

Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • Louisville, Kentucky
  • +75 more
Apr 7, 2022

Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • 2.5mg/d Hetrombopag
  • (no location specified)
Mar 28, 2022

Primary Immune Thrombocytopenia Trial in Worldwide (efgartigimod, Placebo)

Completed
  • Primary Immune Thrombocytopenia
  • efgartigimod
  • Placebo
  • Tucson, Arizona
  • +120 more
Mar 4, 2022

Primary Immune Thrombocytopenia Trial in Worldwide (efgartigimod)

Active, not recruiting
  • Primary Immune Thrombocytopenia
  • efgartigimod
  • Washington, District of Columbia
  • +81 more
Mar 4, 2022

Primary Immune Thrombocytopenia(ITP)

Recruiting
  • Primary Immune Thrombocytopenia
  • Jinan, Shandong, China
    Qilu Hospital, Shandong University
Jun 24, 2021

Primary Immune Thrombocytopenia Trial in Wuhan (rhTPO, eltrombopag)

Unknown status
  • Primary Immune Thrombocytopenia
  • Wuhan, Hubei, China
    Zhou Yiming
Nov 14, 2019

Effect of DNMT SNPs on DNA Methylation in Primary ITP

Unknown status
  • Primary Immune Thrombocytopenia
  • Global DNA methylation will be quantified in the DNA samples by colorimetry
  • (no location specified)
Sep 23, 2019

Primary Immune Thrombocytopenia Trial in Worldwide (ARGX-113, Placebo)

Completed
  • Primary Immune Thrombocytopenia
  • Vienna, Austria
  • +29 more
May 3, 2019